ロード中...

Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study

BACKGROUND: Late-life depression is a common, chronic and recurring disorder for which guidelines recommend long-term therapy. The safety and efficacy of duloxetine for the treatment of major depressive disorder (MDD) were evaluated using data from elderly patients (age ≥ 65 years; n = 101) who part...

詳細記述

保存先:
書誌詳細
主要な著者: Wohlreich, Madelaine M, Mallinckrodt, Craig H, Watkin, John G, Hay, Donald P
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2004
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC544561/
https://ncbi.nlm.nih.gov/pubmed/15585058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2318-4-11
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!